Inmunotek S.L.

24 clinical trials · Sponsor

Record	Firm	Date
Determination of Blomia Tropicalis Allergen Extract in Prick Test Units (NCT07195929)	Inmunotek S.L.	2025-11-01
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df (NCT07348302)	Inmunotek S.L.	2025-04-02
Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte (NCT07427576)	Inmunotek S.L.	2025-03-31
Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions. (NCT06790368)	Inmunotek S.L.	2025-01-01
Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization (NCT06957496)	Inmunotek S.L.	2024-12-09
Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy (NCT06782217)	Inmunotek S.L.	2024-09-01
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract (NCT05641272)	Inmunotek S.L.	2023-11-01
Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation. (NCT05533385)	Inmunotek S.L.	2023-10-10
Study to Evaluate the Ability of Sublingual MV130 to Induce the Expression of Trained Immunity in Peripheral Blood Cells (NCT05208060)	Inmunotek S.L.	2023-09-01
Quercus Ilex and Quercus Robur Allergen Extracts Standardisation (NCT05532566)	Inmunotek S.L.	2023-01-24
Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis (NCT05400811)	Inmunotek S.L.	2022-12-01
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen (NCT04891237)	Inmunotek S.L.	2021-06-14
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses. (NCT04898283)	Inmunotek S.L.	2021-05-31
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis (NCT04874714)	Inmunotek S.L.	2021-04-30
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites (NCT04435990)	Inmunotek S.L.	2020-10-06
Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel (NCT04452643)	Inmunotek S.L.	2020-10-01
Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection (NCT04363814)	Inmunotek S.L.	2020-06-10

Track Inmunotek S.L. automatically

Every clearance here is in the API, with alerts when new ones post.